Stem Cell Reports · 2019 · 38 citations · 47 references
MedicineGeneticsMolecular BiologyCarcinogenesisNeoplasiaNeuro-oncologyCellular ReprogrammingEpigenetic ReprogrammingMetabolic ReprogrammingNeoplastic TransformationOncogene MutationsStem Cell ReprogrammingCell ReprogrammingDisease-associated ReprogrammingGlial Tumor GeneticsNeurofibromatosis Type 1Neurofibromatosis-associated TumorsTranscriptional Reprogramming In CancerTumorigenic Potential Heterogeneity
Neurofibromatosis type 1 (NF1) is a tumor predisposition genetic disease caused by mutations in the NF1 tumor suppressor gene. Plexiform neurofibromas (PNFs) are benign Schwann cell (SC) tumors of the peripheral nerve sheath that develop through NF1 inactivation and can progress toward a malignant soft tissue sarcoma. There is a lack of non-perishable model systems to investigate PNF development. We reprogrammed PNF-derived NF1(-/-) cells, descendants from the tumor originating cell. These NF1(-/-)-induced pluripotent stem cells (iPSCs) captured the genomic status of PNFs and were able to differentiate toward neural crest stem cells and further to SCs. iPSC-derived NF1(-/-) SCs exhibited a continuous high proliferation rate, poor myelination ability, and a tendency to form 3D spheres that expressed the same markers as their PNF-derived primary SC counterparts. They represent a valuable model to study and treat PNFs. PNF-derived iPSC lines were banked for making them available.
47
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 665 citations · Full text
Hiroshi Ban, Naoki Nishishita, Noemi Fusaki et al. · Proceedings of the National Academy of Sciences · 2011 · 599 citations · Full text